Your browser doesn't support javascript.
loading
Targeted delivery of an antibody-mutant human endostatin fusion protein results in enhanced antitumor efficacy.
Shin, Seung-Uon; Cho, Hyun-Mi; Merchan, Jaime; Zhang, Jin; Kovacs, Krisztina; Jing, Yawu; Ramakrishnan, Sundaram; Rosenblatt, Joseph D.
Affiliation
  • Shin SU; Department of Medicine, University of Miami School of Medicine and Sylvester Comprehensive Cancer Center, 1475 N.W. 12th Avenue (D8-4) Miami, FL 33136, USA. sshin@med.miami.edu
Mol Cancer Ther ; 10(4): 603-14, 2011 Apr.
Article in En | MEDLINE | ID: mdl-21393427

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Endostatins / Antibodies / Antineoplastic Agents Type of study: Prognostic_studies Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Endostatins / Antibodies / Antineoplastic Agents Type of study: Prognostic_studies Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States